Filing Details

Accession Number:
0000904454-19-000331
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-18 16:53:14
Reporting Period:
2019-03-14
Accepted Time:
2019-03-18 16:53:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1466301 Clovis Oncology Inc. CLVS Pharmaceutical Preparations (2834) CA
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1024000 C James Blair C/O Domain Associates, Llc
202 Carnegie Center, Suite 104
Princeton NJ 08540
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-03-14 17,056 $27.79 0 No 4 S Indirect By DP VII Associates, L.P.
Common Stock Disposition 2019-03-18 10,000 $0.00 0 No 4 J Indirect By One Palmer Square Associates VII, LLC
Common Stock Acquisiton 2019-03-18 701 $0.00 10,105 No 4 J Indirect By Susan W. and James C. Blair Family L.P.
Common Stock Acquisiton 2019-03-18 522 $0.00 13,439 No 4 J Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By DP VII Associates, L.P.
No 4 J Indirect By One Palmer Square Associates VII, LLC
No 4 J Indirect By Susan W. and James C. Blair Family L.P.
No 4 J Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.67 to $27.94. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  2. The Reporting Person is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of DP VII Associates, L.P. Pursuant to Instruction 4(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities owned by each such entity, however he disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him.
  3. Distribution-in-kind of shares by One Palmer Square Associates VII, LLC, pro rata to its members.
  4. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.